全文获取类型
收费全文 | 8237篇 |
免费 | 431篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 128篇 |
儿科学 | 414篇 |
妇产科学 | 217篇 |
基础医学 | 848篇 |
口腔科学 | 195篇 |
临床医学 | 693篇 |
内科学 | 1882篇 |
皮肤病学 | 144篇 |
神经病学 | 577篇 |
特种医学 | 248篇 |
外科学 | 1606篇 |
综合类 | 171篇 |
一般理论 | 3篇 |
预防医学 | 430篇 |
眼科学 | 180篇 |
药学 | 504篇 |
中国医学 | 36篇 |
肿瘤学 | 432篇 |
出版年
2023年 | 70篇 |
2022年 | 231篇 |
2021年 | 335篇 |
2020年 | 203篇 |
2019年 | 234篇 |
2018年 | 281篇 |
2017年 | 179篇 |
2016年 | 230篇 |
2015年 | 244篇 |
2014年 | 349篇 |
2013年 | 487篇 |
2012年 | 633篇 |
2011年 | 639篇 |
2010年 | 362篇 |
2009年 | 307篇 |
2008年 | 474篇 |
2007年 | 521篇 |
2006年 | 498篇 |
2005年 | 444篇 |
2004年 | 415篇 |
2003年 | 364篇 |
2002年 | 289篇 |
2001年 | 109篇 |
2000年 | 90篇 |
1999年 | 70篇 |
1998年 | 38篇 |
1997年 | 22篇 |
1996年 | 31篇 |
1995年 | 38篇 |
1994年 | 30篇 |
1993年 | 30篇 |
1992年 | 48篇 |
1991年 | 52篇 |
1990年 | 33篇 |
1989年 | 49篇 |
1988年 | 31篇 |
1987年 | 23篇 |
1986年 | 27篇 |
1985年 | 21篇 |
1984年 | 18篇 |
1983年 | 16篇 |
1982年 | 8篇 |
1981年 | 21篇 |
1980年 | 14篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1977年 | 11篇 |
1974年 | 7篇 |
1973年 | 8篇 |
1967年 | 12篇 |
排序方式: 共有8708条查询结果,搜索用时 15 毫秒
81.
Ergün Seyfeli Mehmet Duru Güven Kuvandik Hasan Kaya Fatih Yal?in 《Anadolu kardiyoloji dergisi》2006,6(2):126-129
OBJECTIVE: Increased QTc dispersion is a predictor for ventricular arrhythmias. The aim of this study was to investigate whether QTc dispersion decreases after weight loss program with diet and medical treatment. METHODS: Total 30 (24 women and 6 men, mean age: 44+/-8 years) obese subjects who lost at least 10% of their original weight after 12 week weight loss program were included in present study. Obesity was defined as > or =30 kg/m(2) of body mass index (BMI). Normal weight was defined as < or = 25 kg/m(2) of BMI. RESULTS: After 12 week weight loss program, BMI decreased from 42+/-5 kg/m(2) to 36+/-4 kg/m(2) (p<0.001) and mean weight of obese subjects decreased from 110+/-17 kg to 95+/-15 kg (p<0.001). The mean amount of weight loss was 14.5+/-5.0 kg (range 9-32 kg). The average percent of weight loss was 13% (10.0%-20.3%). Maximum QTc interval (from 446+/-19 ms to 433+/-27 ms, p=0.024) and QTc dispersion (from 66+/-18 ms to 52+/-25 ms, p=0.024) significantly decreased after weight loss program. A statistically significant correlation was found between decrease in level of QTc dispersion and amount of weight loss (r=0.487, p=0.007). CONCLUSION: Substantial weight loss in obese subjects is accompanied by significantly decreased QTc dispersion. The degree of QTc dispersion reduction is associated with amount of weight loss. 相似文献
82.
Derek Leong Ali A. Sovari Ashkan Ehdaie Tarun Chakravarty Qiang Liu Hasan Jilaihawi Rajendra Makkar Xunzhang Wang Eugenio Cingolani Michael Shehata 《Journal of interventional cardiac electrophysiology》2018,52(1):111-116
Background
Damage to the cardiac conduction system requiring permanent pacemaker (PPM) implantation is a known adverse outcome of transcatheter aortic valve replacement (TAVR). A permanent-temporary pacemaker (PTPM) is a device that involves an active-fixation lead attached to an external pulse generator taped to the skin. We reviewed the utility of PTPMs as a temporary bridge measure after TAVR in patients with conduction abnormalities that do not meet conventional criteria for PPM placement.Methods
Between January 01, 2013 and December 31, 2015, we analyzed 67 patients who received PTPM after TAVR. Baseline demographics, comorbidities, type and size of the valve, pre-TAVR electrocardiograms (ECGs), post-TAVR ECGs at 1 day, 1 month, and 6 months, and pacemaker interrogation results were reviewed for each patient if available.Results
The mean age of patients was 80.5?±?9.1 years. PTPM were placed for 2.3?±?2.4 days. Among these patients, 44.8% (n?=?30) received a PPM prior to discharge. Male gender (OR 2.84, 95% CI 1.05–7.69, p?=?0.05) and an increase in QRS duration post-TAVR (p?=?0.01) were associated with PPM placement. Pacemaker interrogation data of 11 patients with PPM revealed that 27% (n?=?3) had <?1% V-pacing requirements and <?10% A-pacing requirements.Conclusions
In post-TAVR patients who develop conduction abnormalities that do not meet conventional PPM implantation indications, PTPM safely provides a time period for further assessment and may prevent unnecessary PPM implantation. Male gender and an increase in QRS duration post-TAVR are associated with PPM implantation. Additionally, some patients may recover from their conduction disturbances and demonstrate low pacemaker utilization.83.
84.
Hasan K. Siddiqi Brittany Weber Guohai Zhou James Regan Jesse Fajnzylber Kendyll Coxen Heather Corry Xu G. Yu Marcelo DiCarli Jonathan Z. Li Deepak L. Bhatt 《The American journal of medicine》2021,134(4):542-546
BackgroundPatients with coronavirus disease 2019 (COVID-19) have a high prevalence of detectable troponin and myocardial injury. In addition, a subset of patients with COVID-19 has detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral loads. The objective of this study was to understand the relationship among SARS-CoV-2 viremia, detectable troponin, and myocardial injury in hospitalized patients with COVID-19.MethodsSARS-CoV-2 plasma viral load was measured in plasma samples drawn from patients hospitalized for COVID-19 at 2 academic medical centers. Baseline characteristics and clinically obtained high-sensitivity cardiac troponin T (hs-cTnT) values were abstracted from the medical record. The main outcome was detectable hs-cTnT (≥6 ng/mL) and myocardial injury (hs-cTnT ≥14 ng/mL; >99th percentile for assay).ResultsA total of 70 hospitalized patients with COVID-19 were included in this study, with 39% females and median age 58 ± 17 years; 21 patients (30%) were found to have detectable SARS-CoV-2 viral load and were classified in the viremia group. Patients with viremia were significantly older than those without viremia. All of the patients with viremia (100%) had detectable troponin during hospitalization compared with 59% of patients without viremia (P = 0.0003). Myocardial injury was seen in 76% of patients with viremia and 38% of those patients without viremia (P = 0.004).ConclusionsHospitalized patients with COVID-19 with SARS-CoV-2 viremia have a significantly higher prevalence of detectable troponin and myocardial injury during their hospitalization compared with patients who did not. This first report of the relationship among SARS-CoV-2 viremia, detectable troponin, and myocardial injury in patients with COVID-19 points to additional mechanistic pathways that require deeper study to understand the complex interplay among these unique findings, cardiovascular outcomes, and mortality in COVID-19. 相似文献
85.
86.
Jadidi Nilofar Alesaeidi Samira Arab Fatemeh Pakzad Bahram Siasi Elham Esmaeilzadeh Emran 《Clinical rheumatology》2022,41(11):3487-3494
Clinical Rheumatology - MiRSNPs may interfere with mRNA stability through effects on microRNAs (miRNAs)-mRNA interactions via direct changes in miRNA binding site or effect on the secondary... 相似文献
87.
Yardimci H van Duffelen M Mao Y Rosenfeld SS Selvin PR 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(16):6016-6021
In vivo studies suggest that centromeric protein E (CENP-E), a kinesin-7 family member, plays a key role in the movement of chromosomes toward the metaphase plate during mitosis. How CENP-E accomplishes this crucial task, however, is not clear. Here we present single-molecule measurements of CENP-E that demonstrate that this motor moves processively toward the plus end of microtubules, with an average run length of 2.6 +/- 0.2 mum, in a hand-over-hand fashion, taking 8-nm steps with a stall force of 6 +/- 0.1 pN. The ATP dependence of motor velocity obeys Michaelis-Menten kinetics with K(M,ATP) = 35 +/- 5 muM. All of these features are remarkably similar to those for kinesin-1-a highly processive transport motor. We, therefore, propose that CENP-E transports chromosomes in a manner analogous to how kinesin-1 transports cytoplasmic vesicles. 相似文献
88.
Many patients do not respond clinically to cardiac resynchronization therapy (CRT), despite clinical and survival benefits demonstrated in numerous clinical trials. This has led to focused evaluation from preimplant issues, as to who is an appropriate candidate for CRT, to postimplant issues, more specifically, optimizing device programming in CRT. CRT studies have used simultaneous biventricular pacing, but with advancing echocardiographic technology, the role of dyssynchrony, or mechanical delay in contraction of the ventricles, suggests that individually tailoring ventricular pacing improves hemodynamics. Atrial to ventricular timing affects left ventricular filling and cardiac output, whereas the right to left ventricular pacing delay also improves systolic and diastolic performance. The importance of device programming parameters and optimal pacing delays in biventricular pacing is reviewed in this article. 相似文献
89.
Dizon J Reiffel J Kassotis J Woollett I Garan H 《Journal of cardiovascular electrophysiology》2003,14(5):461-466
INTRODUCTION: Despite the great success in treating AV nodal reentrant tachycardia (AVNRT) with radiofrequency modification of the AV node, the dimensions of the electrophysiologic circuit of this arrhythmia remain unclear, and simple models fail to explain all tachycardia-related phenomena. METHODS AND RESULTS: We describe three unusual cases of supraventricular tachycardia (SVT). In all three cases, retrograde atrial activation during ventricular pacing or during SVT manifested local left atrial electrograms recorded from the coronary sinus preceding the septal atrial electrograms (eccentric activation), with earliest atrial activity at the lateral or posterolateral mitral annulus. Electrophysiologic maneuvers and observations were consistent with AVNRT as the mechanism in each case. In all cases, radiofrequency modification of the AV node eliminated inducible SVT and abolished dual pathway AV nodal physiology. The retrograde atrial activation sequence during ventricular pacing changed after ablation in each case, with septal atrial electrograms preceding left atrial electrograms recorded from the coronary sinus (concentric activation). CONCLUSION: The observations in these cases cannot be explained by the traditional model of slow, fast, and intermediate AV nodal pathways. A model incorporating a circuit close to the AV node with left atrial and coronary sinus connections is proposed. 相似文献
90.
E J Ladusans S A Qureshi J M Parsons S Arab E J Baker M Tynan 《British heart journal》1990,63(6):362-367
Percutaneous balloon dilatation was attempted in 15 consecutive neonates (mean age 7.3 (range 1-27) days and weight 3.2 (range 2.5-4.1) kg) with critical stenosis of the pulmonary valve. Dilatation was successful in 11 (73%) patients. The mean balloon to annulus ratio was 1.1 (range 0.6-1.77). The ratio of right ventricle to femoral artery systolic pressure decreased from a mean (1 SD) of 1.4 (0.32) before to 0.8 (0.24) after dilatation and the transvalvar gradient decreased from 81 (29.7) mm Hg before to 33 (27.7) mm Hg after dilatation. All four (27%) patients in whom dilatation was unsuccessful underwent surgical valvotomy. Complications of balloon dilatation occurred in three (20%) patients; these included retroperitoneal haematoma (one) and iliofemoral venous occlusion (two). In one (7%) patient severe hypoxia and hypotension developed when the valve was crossed with a guide wire and balloon catheter. Despite successful dilatation he died 7 days after the procedure. During a mean (1 SD) follow up of 2 (1.7) years, seven (64%) of the 11 patients remained free of important restenosis. One patient required repeat dilatation three weeks after the initial procedure. In three (27%) patients restenosis developed 4-9 months after dilatation and all three had surgical valvotomy. Of the four patients initially referred for surgery three required a second operation and one required balloon dilatation. Percutaneous balloon dilatation gave effective relief of critical pulmonary stenosis in most neonates but complications and restenosis requiring surgery were common. 相似文献